Santé & Pharma

Modus Therapeutics Holding AB (publ)

Modus Therapeutics Holding AB (publ)

53,8M

Mohini Health & Hygiene Limited

1,1B

Molecular Partners AG

118,2M

Molecular Partners Ltd

125,3M

Molecular Templates, Inc.

Moleculin Biotech, Inc.

2,9M

Molina Healthcare, INC.

10,3B

Monopar Therapeutics

730,8M

Monte Rosa Therapeutics, Inc.

1,4B

MoonLake Immunotherapeutics

1,6B

Morepen Laboratories Limited

31,3B

Morphic Holding, Inc.

Motion Acquisition Corp.

Motus GI Holdings, Inc.

638

Mountain Crest Acquisition Corp. III

Movano Inc.

379,4M

MultiPlan Corp

MusclePharm Corp

Mustang Bio, INC.

4,6M

MyMD Pharmaceuticals, Inc.

Myovant Sciences Ltd.

Myriad Genetics INC

311,8M

Mysafety Group

433,4M

NAN

1,1B

NANOBIOTIX

1,7B

NASDAQ STOCKHOLM AKTIEBOLAG

7,8B

NATURAL ALTERNATIVES INTERNATIONAL INC

14,7M

NEKTAR THERAPEUTICS

2,6B

NEOGEN CORP

2,5B

NEOVACS

34

NEPHROS INC

45,7M

NETCARE LIMITED

21,9B

NEUROONE MEDICAL TECHNOLOGIES Corp

14,2M

NEVRO CORP

NEXGEL, INC.

NFL Biosciences

11M

NGL Fine-Chem Limited

20,1B

NGM Biopharmaceuticals INC

NICOX SA

37,6M

NOLATO AKTIEBOLAG

12,8B

NOVATION COMPANIES, INC.

NOVAVAX INC

1,3B

NRX Pharmaceuticals, Inc.

NTI

19,8M

NU Skin Enterprises, INC.

266,5M

NUVASIVE INC

NUZ

48,8M

Nabriva Therapeutics plc

Namn: Vimian Group AB (publ)